Cynata Therapeutics achieves progress in stem cell technology – Proactive Investors USA & Canada
Proactive Investors USA & Canada |
Cynata Therapeutics achieves progress in stem cell technology
Proactive Investors USA & Canada Cynata Therapeutics (ASX:CYP) has received the Notice of Allowance from the U.S. patent office for a patent application tied to its proprietary Cymerus™ stem cell technology. This patent application covers an important element of Cynata's stem cell … |
